This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Medivir Ab. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Claudio Sturino: Innovator in Respiratory Syncytial Virus Inhibitors
Introduction
Claudio Sturino is a notable inventor based in Burlington, CA. He has made significant contributions to the field of medicinal chemistry, particularly in the development of inhibitors for respiratory syncytial virus (RSV). His work is crucial in the ongoing battle against viral infections that affect millions worldwide.
Latest Patents
Sturino holds a patent for "Respiratory syncytial virus inhibitors - Compounds of Formula (I)," wherein R, R, R, R, and n are defined herein, which are useful as inhibitors of RSV. This patent represents a significant advancement in the search for effective treatments against this common respiratory virus. He has 1 patent to his name.
Career Highlights
Claudio Sturino is currently employed at Medivir AB, a company known for its focus on antiviral therapies. His role involves extensive research and development aimed at creating innovative solutions for viral infections. His expertise in this area has positioned him as a valuable asset to his team and the broader scientific community.
Collaborations
Sturino collaborates with talented professionals in his field, including Araz Jakalian and Patrick Deroy. These partnerships enhance the research efforts at Medivir AB and contribute to the advancement of antiviral therapies.
Conclusion
Claudio Sturino's work in developing respiratory syncytial virus inhibitors showcases his dedication to improving public health through innovation. His contributions are vital in the ongoing fight against viral infections, and his collaborations further strengthen the impact of his research.